Visceral Leishmaniasis (VL or Kala azar) is a disease of poor and neglected populations; it affects 79 countries of the world and accounts 58, 000 new cases to each year [1]. Indian subcontinent covers 90% VL cases of the world, among which Bihar state accounts for most cases [2]. In absence of antileishmanial vaccines early and accurate diagnosis holds the key for the control of VL. Till date parasitological method remains the gold standard for diagnosing VL. Microscopic demonstration of amastigotes in splenic aspirates, peripheral blood mononuclear cells and buffy coat has been shown to possess high sensitivities and absolute specificity [3,4]. Serology based diagnostic methods to detect antibodies against different recombinant Leishmania antigens (rK39, rK28, rK16) are also routinely employed to detect active cases in the field conditions. Out of these rK39 immunochromatographic test (ICT) remains the test of choice for clinicians because of its 100% sensitivity in VL subjects and 85-100% specificity in endemic healthy controls [5]. Recently recombinant antigen rK16, 39-amino acid protein obtained from C terminus of L. donovani immobilized in two different formats, a flow through test (KEFT) or Signal KA, and a lateral flow test (KELF) or Crystal KA had shown higher (sensitivity 93-99% and 99.5% respectively) in Indian subcontinent than East Africa and Brazilian VL subjects [6,7]. rK28 was designed to increase antigen epitope density from L. donovani haspb1 and rK39 kinesin gene. In ELISA, it has shown 100% sensitivity in VL subjects and 94% specificity in endemic healthy controls [6]. Antibody based detection methods have two major limitations. Although antibody titre level goes down after successful VL treatment, it still can be detected after many years. Secondly, house hold contacts from VL patient families have shown positivity for antileishmanial antibodies. Sero-prevalence in these individuals varies from 10-30% and they are termed as asymptomatic cases. Therefore, antibody based approaches should be confirmed with other VL defining tools before treatment [8]. In order to develop non invasive diagnosis for VL, the strip tests have been evaluated using human saliva which is a good source of anti-leishmanial antibodies. Sensitivity for rK39 antigen using saliva was 83.3% and 82.5% in ELISA and ICT technique, whereas specificity was found to be 90.5% and 91.5% respectively by ELISA and ICT in endemic healthy controls [9]. A recent study from Bangladesh has shown satisfactory results with urine samples of VL patients and endemic controls with rK39 based ICT (93.3% specificity and 95% sensitivity) [10]. Since the reliability of these RDTs in any region depends upon the manufacturer, therefore quality and performance should be checked before implementing these RDTs for VL diagnostic algorithm. In immune-compromised patients (HIV-VL co-infection) antibody titre is low therefore RDTs should be evaluated properly in clinical settings to define VL subjects and treatment recommendations.Antigen based diagnosis is...